Neuphoria receives $15M milestone payment from Merck
BURLINGTON, Mass. - Neuphoria Therapeutics Inc. (NASDAQ:NEUP), a biotechnology firm focused on neuropsychiatric treatments with a market capitalization of $7.27 million, is set to receive a $15 ...
SpringWorks shares rise on FDA nod for GOMEKLI
Shares of SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) climbed 2.7%, building on a previous gain of 2%, following the FDA ...